Eli Lilly and Company
LLY
$1,059.70
$16.411.57%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.13% | 22.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.13% | 22.23% | |||
| Cost of Revenue | 22.90% | 10.05% | |||
| Gross Profit | 11.31% | 24.81% | |||
| SG&A Expenses | -0.79% | 12.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.94% | 15.18% | |||
| Operating Income | 19.28% | 31.76% | |||
| Income Before Tax | 6.73% | 96.07% | |||
| Income Tax Expenses | 47.85% | 60.15% | |||
| Earnings from Continuing Operations | -1.38% | 105.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.38% | 105.14% | |||
| EBIT | 19.28% | 31.76% | |||
| EBITDA | 17.95% | 29.53% | |||
| EPS Basic | -1.27% | 105.33% | |||
| Normalized Basic EPS | 20.53% | 30.96% | |||
| EPS Diluted | -1.27% | 105.56% | |||
| Normalized Diluted EPS | 20.53% | 30.96% | |||
| Average Basic Shares Outstanding | -0.11% | -0.09% | |||
| Average Diluted Shares Outstanding | -0.11% | -0.09% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.01% | -0.51% | |||